ATM signaling pathway (WP654)

Rattus norvegicus

Authors

Ralph Straus , Thomas Kelder , Christine Chichester , Martina Summer-Kutmon , Kristina Hanspers , Eric Weitz , and Lars Willighagen

Activity

last edited

Discuss this pathway

Check for ongoing discussions or start your own.

Cited In

Are you planning to include this pathway in your next publication? See How to Cite and add a link here to your paper once it's online.

Organisms

Rattus norvegicus

Communities

Annotations

Pathway Ontology

ataxia telangiectasia-mutated (ATM) signaling pathway p53-dependent G1/S DNA damage checkpoint pathway

Participants

Label Type Compact URI Comment
H2afx GeneProduct ncbigene:300668
Rb1 GeneProduct ncbigene:24708
Apaf1 GeneProduct ensembl:ENSRNOG00000008022
Cdk2 GeneProduct ncbigene:362817
Reprimo GeneProduct ncbigene:680110
Bcl2 GeneProduct ncbigene:24224
Tp53 GeneProduct ncbigene:24842
Bax GeneProduct ncbigene:24887
Atm GeneProduct ncbigene:300711
14-3-3 sigma GeneProduct ncbigene:298795
CytC GeneProduct ncbigene:25309
Cyclin D GeneProduct ncbigene:58919
CyclinB1 GeneProduct ncbigene:25203
Cdk6 GeneProduct ncbigene:114483
Chk2 GeneProduct ncbigene:114212
Cyclin E GeneProduct ncbigene:25729
Caspase9 GeneProduct ncbigene:58918
Brca1 GeneProduct ncbigene:497672
E2f1 GeneProduct ncbigene:399489
Cdkn1a GeneProduct ensembl:ENSRNOG00000000521
Caspase3 GeneProduct ncbigene:25402
Cdc2 GeneProduct ncbigene:54237
Pmaip1 GeneProduct ncbigene:492821
Gadd45a GeneProduct ncbigene:25112
Bak1 GeneProduct ncbigene:116502

References

  1. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. Cell. 1993 Nov 19;75(4):805–16. PubMed Europe PMC Scholia
  2. Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Kothakota S, Azuma T, Reinhard C, Klippel A, Tang J, Chu K, et al. Science. 1997 Oct 10;278(5336):294–8. PubMed Europe PMC Scholia
  3. Bax directly induces release of cytochrome c from isolated mitochondria. Jürgensmeier JM, Xie Z, Deveraux Q, Ellerby L, Bredesen D, Reed JC. Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):4997–5002. PubMed Europe PMC Scholia
  4. Reprimo, a new candidate mediator of the p53-mediated cell cycle arrest at the G2 phase. Ohki R, Nemoto J, Murasawa H, Oda E, Inazawa J, Tanaka N, et al. J Biol Chem. 2000 Jul 28;275(30):22627–30. PubMed Europe PMC Scholia
  5. BRCA1-induced large-scale chromatin unfolding and allele-specific effects of cancer-predisposing mutations. Ye Q, Hu YF, Zhong H, Nye AC, Belmont AS, Li R. J Cell Biol. 2001 Dec 10;155(6):911–21. PubMed Europe PMC Scholia
  6. Histone H2A variants H2AX and H2AZ. Redon C, Pilch D, Rogakou E, Sedelnikova O, Newrock K, Bonner W. Curr Opin Genet Dev. 2002 Apr;12(2):162–9. PubMed Europe PMC Scholia
  7. Cell cycle arrest and repression of cyclin D1 transcription by INI1/hSNF5. Zhang ZK, Davies KP, Allen J, Zhu L, Pestell RG, Zagzag D, et al. Mol Cell Biol. 2002 Aug;22(16):5975–88. PubMed Europe PMC Scholia
  8. The multiple nuclear functions of BRCA1: transcription, ubiquitination and DNA repair. Starita LM, Parvin JD. Curr Opin Cell Biol. 2003 Jun;15(3):345–50. PubMed Europe PMC Scholia
  9. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Chipuk JE, Kuwana T, Bouchier-Hayes L, Droin NM, Newmeyer DD, Schuler M, et al. Science. 2004 Feb 13;303(5660):1010–4. PubMed Europe PMC Scholia
  10. G2 cell cycle arrest, down-regulation of cyclin B, and induction of mitotic catastrophe by the flavoprotein inhibitor diphenyleneiodonium. Scaife RM. Mol Cancer Ther. 2004 Oct;3(10):1229–37. PubMed Europe PMC Scholia
  11. ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage. Chen L, Gilkes DM, Pan Y, Lane WS, Chen J. EMBO J. 2005 Oct 5;24(19):3411–22. PubMed Europe PMC Scholia